We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Subscribe to JAMA Psychiatry for 12 months of high-impact, peer-reviewed original articles and unique features. Subscribe/Learn More

Current Highlights

Follow Us

Original Investigation | July 27, 2016 FREE ONLINE FIRST

Association Between PET-Measured Serotonergic Activity and Suicide

This cohort study investigates associations between PET-measured lower midbrain serotonin transporter binding potential and future suicide attempts, intent, and lethality in patients with major depressive disorder.

Original Investigation | July 20, 2016 ONLINE FIRST

Effect of Adjunctive Raloxifene Therapy in Refractory Schizophrenia

This randomized trial compares the effects of adjunctive raloxifene with antipsychotic therapy vs antipsychotics alone on illness severity in women with refractory schizophrenia.

Original Investigation | July 13, 2016 ONLINE FIRST

Triggers of Violence in Patients With Psychotic Disorders

This study uses Swedish national registry data to identify triggers for violent behavior in patients with schizophrenia spectrum and bipolar disorders, and to compare risk in those populations vs healthy controls.

Original Investigation | July 6, 2016 ONLINE FIRST

Polygenic Risk of Psychosis and Ventral Striatal Activation in Adolescents

This cross-sectional study examines whether common risk variants for psychosis are associated with individual variation in the ventral striatum.

Original Investigation | June 29, 2016 ONLINE FIRST

Cognitive Behavior Therapy With D-Cycloserine in Pediatric OCD

This randomized clinical trial compares the effects of cognitive behavior therapy augmented with weight-adjusted d-cycloserine vs placebo on obsessive-compulsive disorder symptoms among youth with OCD.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Maria A. Oquendo, MD, author of Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior

audio player


Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior

All Author Interviews >

Article Video

Video thumbnail

The Tradition and Future of JAMA Psychiatry (02:22)

Stephan Heckers, MD, Editor, provides an overview of JAMA Psychiatry.

All Article Videos >


Interactive preview

All Interactive >

Author Readings
Author photo

audio player


Reader Comments

Introducing Reader Comments, a new way for readers to discuss JAMA Psychiatry articles. Select the Comments tab on article pages to read any comments and submit your own. Letters submitted to JAMA Psychiatry for consideration for print and online (archival) publication but not accepted may be accepted as Comments.

Firearm Violence

Articles from the JAMA Network

Image of JAMA forum logo

Physician Jobs